A carbamazepine trial in chronic, treatment-refractory schizophrenia
- 1 June 1988
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 145 (6) , 748-750
- https://doi.org/10.1176/ajp.145.6.748
Abstract
Carbamazepine was given to 12 chronic, treatment-refractory schizophrenic patients for 5 weeks. No overall change was found, but four patients significantly improved while eight worsened. Given the paucity of successful treatments for refractory schizophrenia, further study of carbamazepine appears warranted.This publication has 2 references indexed in Scilit:
- Antidepressant effects of carbamazepineAmerican Journal of Psychiatry, 1986
- CARBAMAZEPINE AS ADJUNCTIVE TREATMENT IN NON-EPILEPTIC CHRONIC INPATIENTS WITH EEG TEMPORAL-LOBE ABNORMALITIES1983